These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Use of chrysotherapy in the treatment of rheumatoid arthritis]. Dormidontov EN; Korshunov NI; Baranova EIa Ter Arkh; 1981; 53(7):78-80. PubMed ID: 7292322 [No Abstract] [Full Text] [Related]
25. [Rheumatology. Side effects of chrysotherapy]. Serre H; Sany J; Rosenberg F Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):552-9. PubMed ID: 137685 [No Abstract] [Full Text] [Related]
26. [Thrombopenia and chrysotherapy. Apropos of a personal case]. Levy R; Brochard C; Alterescu R Ann Med Interne (Paris); 1976 AUG-SEP; 127(8-9):571-2. PubMed ID: 1008380 [No Abstract] [Full Text] [Related]
27. [Effectiveness and complications of chrysotherapy of rheumatoid arthritis]. Erov NK Revmatologiia (Mosk); 1986; (1):11-4. PubMed ID: 2940663 [No Abstract] [Full Text] [Related]
28. [Personal experience with the effect of a treatment with colloidal gold sulfide in rheumatoid arthritis]. Frizziero L; Facchini A; Zizzi F Reumatismo; 1977; 29(2-3):148-53. PubMed ID: 616961 [No Abstract] [Full Text] [Related]
29. [Oral lichenoid reaction secondary to gold salt therapy]. Vallejo Irastorza G; López Cedrún JL; Marínez-Conde R; Aguirre Urízar JM Av Odontoestomatol; 1990 Feb; 6(2):131-3. PubMed ID: 2118353 [TBL] [Abstract][Full Text] [Related]
30. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction. Stein HB; Ruedy J; Atkins CJ; Offer RC Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126 [TBL] [Abstract][Full Text] [Related]
31. Influence of gold salts on the content of trace elements in serum of patients with rheumatoid arthritis under sanocrysin treatment. Dawczynski H; Winnefeld K; Tanner E; Tennigkeit E Arch Toxicol Suppl; 1980; 4():483-4. PubMed ID: 6776937 [TBL] [Abstract][Full Text] [Related]
32. Analysis of treatment terminations with gold and antimalarial compounds in rheumatoid arthritis. Richter JA; Runge LA; Pinals RS; Oates RP J Rheumatol; 1980; 7(2):153-9. PubMed ID: 7373617 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcome with gold thiosulphate and tiopronin in 200 rheumatoid patients. Ferraccioli GF; Salaffi F; Nervetti A; Manganelli P Clin Exp Rheumatol; 1989; 7(6):577-81. PubMed ID: 2515016 [TBL] [Abstract][Full Text] [Related]
34. Chrysotherapy: pharmacological and clinical correlates. Lorber A; Simon TM; Leeb J; Carroll PE J Rheumatol; 1975 Dec; 2(4):401-10. PubMed ID: 1206672 [TBL] [Abstract][Full Text] [Related]
35. [The prevention of chrysotherapy complications in patients with rheumatoid arthritis]. Berezhnitskiĭ MN; Ornat SIa; Aleksandruk DP Vrach Delo; 1989 Apr; (4):55-7. PubMed ID: 2756689 [TBL] [Abstract][Full Text] [Related]
36. [Neurologic complications of chrysotherapy. Apropos of 2 cases, 1 with Guillain-Barre syndrome]. Bontoux D; Lefevre JP; Medejel A; Daban M Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):48-51. PubMed ID: 4820527 [No Abstract] [Full Text] [Related]
37. [Clinical picture of rheumatic diseases. Current position of gold therapy]. Meyer W Verh Dtsch Ges Rheumatol; 1974; 3(0):260-8. PubMed ID: 4276008 [No Abstract] [Full Text] [Related]